Dakang Chen Shaobo: The hemodialysis market should make a big increase, do a good stock

Chronic renal failure in the terminal phase, also known as uremia, hemodialysis is a common treatment to help patients survive, but the cost of treatment is difficult for many families to afford. It is understood that the annual average cost of hemodialysis is as high as tens of thousands to hundreds of thousands. The fees vary from place to place. In addition, uremia is a "protracted war". On average, two days go, if one or two weeks are not When doing dialysis, patients are at risk of life. For the majority of the grassroots, the cost of the road has also caused many patients to give up treatment. Before 2010, there were more than 600 dialysis institutions in more than 2,800 counties across the country, and 70% did not.

After the “Independent Dialysis Room” incident in Tongzhou, Beijing in 2009, the government departments increased their attention to this category of vulnerable groups. In addition to continuously improving the reimbursement system for medical insurance, the pilot of the independent hemodialysis center of the former Ministry of Health in 2010 was also a major measure. By establishing an independent hemodialysis center at the grassroots level to sink high-quality medical resources, Dakang Medical was one of the first pilots. enterprise.

As a pioneer in independent hemodialysis centers, many people say that Dakang is lucky and forward-looking. Chen Shaobo, chairman of Dakang Medical, believes: "It's not good luck, the independent hemorrhagic center is something that comes into being. Dakang is doing the right thing at the right time."

China's hemodialysis market: making large increments, making excellent stocks

At present, Dakang Medical has established and operated more than 100 independent blood purification centers and kidney disease specialist hospitals in 14 provinces and cities including Jiangxi, Shandong, Hebei, Shanxi and Guangdong.

Chen Shaobo once said that it is of little significance to be a single independent third-party medical service organization, and chaining is an inevitable trend. He explained to the health of Yiou, that a single independent store and chain is a different profit model. For a single independent hemodialysis center, the nephrologist can use the additional labor for medical services in his spare time, with the necessary medical staff, equipment and medicines to operate, the cost is relatively low. However, for companies such as Dakang Medical, standardization and unified management are required, and only continuous expansion can reduce costs. For example, the development of information systems requires millions of dollars, and a store can't afford it.

Does chaining also stem from the Chinese market? In 2010, when Dakang conducted the “Independent Hemodialysis Center Pilot” project, about 160,000 patients received dialysis services nationwide. After three years of development, the number of patients was over 300,000. According to Japanese data, China and Japan belong to the same species. Japan has a population of 130 million. The number of patients receiving dialysis services is 320,000. The population of China's 1.4 billion is almost ten times that of China. China should have 200. 3 million patients received dialysis services. It seems that China's HX market is huge, and it is a market that is in short supply.

Chen Shaobo said: "This is a misunderstanding." He explained that normal should have about 3 million patients undergoing dialysis, but 3 million patients are not stock markets. According to the incidence of 0.01% to 0.015% of global uremia, China's 1.4 billion people, theoretically, add about 140,000 to 200,000 uremic patients each year. However, due to the imbalance of economic capacity and medical resources, only a few hundred thousand patients are now dialysis. The dialysis market relies on the improvement of the quality of medical services to improve the survival rate of patients, and the increase in inventory can gradually reach the market of 2 million to 3 million.

In addition, he added, through the sinking of high-quality medical resources, coupled with the government's more support in people's livelihood security, China's Hemodialysis market is sufficient in the future, and all parties need to work together to make large increments and do superior stocks. . Nowadays, the number of patients who have passed through from 160,000 in 2010 to 2017 is close to 670,000. Objectively speaking, more than 90% of patients in the future will be able to get dialysis.

In the future, hemodialysis is a meager profit industry.

The issuance of Document 67 of the Health Planning Commission in December 2016 means that the independent hemodialysis center has been fully promoted to the medical market, and has formed a unified national norm. The independent hemodialysis center has developed rapidly. By the end of 2017, more than 200 independent hemodialysis centers have been opened nationwide.

In addition to the large number of domestic enterprises entering the Hemodialysis market, foreign companies have begun to lay out the Chinese Hemodialysis market. In the global hemodialysis field, Fresenius can account for 11%, and another major company is DaVita. In 2017, the two companies began to enter the Chinese market.

Talking about whether the entry of foreign companies will put pressure on domestic enterprises such as Dakang, Chen Shaobo said that he did not. From the perspective of service alone, the number of domestic dialysis institutions is far from enough, but it is phased, and the relative shortage is not an absolute deficiency. China is very large and needs a lot. It needs to be quickly laid out and developed. It also plays a great role in promoting the entire industry, allowing more people with uremia to survive. In terms of medical costs, for Da Kang, its bargaining power is improving, and the gap in cost is not large. In addition, in fact, local companies will be more accustomed to China's relatively different national conditions.

For the current profitability of the hemodialysis market, Chen Shaobo clearly stated: “I will not pay for it!” He explained to the health of the billion euros that hemodialysis is a basic medical service. The charging standard was established in 1992. I haven't made adjustments for so many years, and I can't pay for it, but I can't afford to lose money, endure loneliness, calmly grasp medical safety and quality, and build a brand that reassures patients.

He added that the radius of a dialysis center service and the space that can be expanded exist in the ceiling, and the labor cost is rising. In the future, hemodialysis is a meager profit.

Teeth Cleaning Equipment

Teeth Whitening Machine,Desktop Model Tooth Light,Teeth Bleaching Machine ,Dental Teeth Whitening Machine

Foshan Ja Suo Medical Device Co., LTD , https://www.jasuodental.com